PCN69 PHARMACOECONOMIC ANALYSIS OF THE ADDITION OF RITUXIMAB TO FIRST-LINE CHEMOTHERAPY TREATMENT REGIMENS IN SPANISH PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA
Abstract
Authors
C Rubio-Terrs J Gmez-Codina E Ros Herranz AJ Castro C Varela JA Ray